Colorectal cancer (CRC) stands as the third most prevalent ailment globally and represents
the primary cause of mortality associated with cancer. Significant advancements have been …

Pulmonary fibrosis is a chronic and progressive lung disease characterized by the
accumulation of scar tissue in the lungs, which leads to impaired lung function and reduced …

Idiopathic pulmonary fibrosis (IPF) is an irreversible and life-threatening lung disease of
unknown etiology presenting only a few treatment options. TGF-β signaling orchestrates a …

Hepatocellular carcinoma (HCC) is the third foremost cause of cancer-related deaths. HCC
has a very bad prognosis because it is asymptomatic in the early stages, resulting in a late …

Liver fibrosis is a progressive condition characterized by the build-up of fibrous tissue
resulting from long-term liver injury. Although there have been advancements in research …

Liver cancer stands as the fourth leading global cause of death, and its prognosis remains
grim due to the limited effectiveness of current medical interventions. Among the various …

Doxorubicin (DOX) is a widely used powerful anthracycline for treatment of many varieties of
malignancies; however its cumulative and dose-dependent cardio-toxicity has been limited …

Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease with a poor
prognosis. There is currently no definitive cure for IPF. The present study establishes a …

Hepatic fibrosis arising from chronic liver injury is characterized by dysregulated healing,
including hepatic stellate cell activation and excessive deposition of extracellular matrix …

Lung cancer is one of the mortal cancers and the leading cause of cancer-related mortality,
with a cancer survival rate of fewer than 5% in developing nations. This low survival rate can …